IRDM Forecast



Bearish   ↔   Bullish



80% Confidence




Bullish Case: Options flow is call-heavy (95% more call volume), with the 11/20 $50C and $55C drawing real interest at 32–35% IV. Rocket Lab's pending mid-2027 acquisition implies shareholders receive RKLB stock plus cash consideration near current value; RKLB's record $2.36B backlog and >$1B new Q3 contracts support deal completion. Spot is +163% YoY with momentum intact, and Helium's PDF puts peak density at $50–55, just above spot $48.96.




Bearish Case: RKLB at $74 is 51% off its May peak and funding the deal via $1.94B dilutive equity sales—if RKLB keeps falling or financing wobbles, deal spread risk hits IRDM. The Helium PDF shows a fat left tail (density at $30–45 exceeds market pricing at 45), and long-dated put IVs (40%+) price persistent downside skew. Post-rally mean reversion after +163% YoY and thin options liquidity (3rd percentile) argue for chop, not continuation.




Potential Outcomes:
  1. 30% Range $46–52 into November expiry (mean-reverting tape; flat term structure; Helium AI +1.15% vs -0.1 correlation)
  2. 25% Pullback -8–12% toward $43–45 if RKLB slides or deal headlines sour (Helium PDF left-tail heavier than market)
  3. 20% Rally +10–15% on deal-clearance progress or Q3 results (call dominance, 11/20 55C volume)
  4. 15% Grind higher +5–8% as spread narrows toward deal value
  5. 10% Tail drop -25%+ on deal break/regulatory shock (deep put IV 55–70% pricing this)



October 03, 2026















See risk, trade-offs, and measured results before you decide.